Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza for cancer-related neuropathic pain
NCT03317613Phase 2Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Nov 2017
- Primary completion
- Dec 2020
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin 8% patch in neuropathic pain, sponsored by CHU Saint-Etienne. Started Nov 2017; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03317613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317613.